I now have comprehensive content from multiple authoritative sources. Here is the complete, detailed management guide:
Management of Snakebite - Comprehensive Clinical Guide
1. Epidemiology and Background
Snakebite is the deadliest neglected tropical disease in the world. Global data from 2019 estimate 63,415 deaths from snake envenomation annually, with a projected rise to ~68,800 by 2030 despite WHO goals to halve mortality. There are an estimated 1.2-5.5 million snakebites worldwide each year, with 421,000-1,200,000 envenomations. The majority occur in developing countries, especially in agricultural and fishing communities in tropical and subtropical climates. Most victims are young males, with up to 60% of bites occurring in individuals who were deliberately provoking the snake.
- Harrison's Principles of Internal Medicine, 22nd Ed.
2. Classification of Venomous Snakes
| Family | Key Species | Venom Type |
|---|
| Viperidae - Crotalinae (pit vipers) | Rattlesnakes, copperheads, water moccasins, Asian pit vipers | Cytotoxic, hemotoxic |
| Viperidae - Viperinae (true vipers) | Russell's viper, saw-scaled viper, puff adder | Cytotoxic, hemotoxic |
| Elapidae | Cobras, kraits, mambas, coral snakes, sea snakes, Australian species | Neurotoxic |
| Lamprophiidae (Atractaspidinae) | Burrowing asps | Cardiotoxic |
| Colubridae | Rear-fanged colubrids | Mostly mild |
"Dry bites" - approximately 20-25% of pit viper bites and up to 75% of sea snake bites release no venom. All bites must initially be treated as potentially venomous until ruled out.
India's "Big Four": Russell's viper (Daboia russelii), common krait (Bungarus caeruleus), Indian cobra (Naja naja), and saw-scaled viper (Echis carinatus) account for the majority of snakebite deaths on the subcontinent.
3. Pathophysiology of Venom
Crotaline (Pit Viper) Venom
A complex enzyme mixture causing:
- Local tissue injury via proteolytic enzymes, collagenase, elastase
- Vascular damage - increased permeability, plasma extravasation, hypovolemia
- Hematologic effects - fibrinogenolysis, platelet consumption, coagulopathy/DIC
- Hemolysis via phospholipase A2
- Neurotoxicity (in some species) - blocks neuromuscular transmission causing ptosis, respiratory failure
Elapid Venom
Primarily neurotoxic - pre- and post-synaptic neurotoxins cause:
- Tremor, salivation, dysarthria, diplopia
- Bulbar paralysis, ptosis, fixed pupils
- Dysphagia, dyspnea, respiratory muscle failure
- Cobras additionally cause severe local pain and necrosis
Key Venom Enzymes
Phospholipase A2, hyaluronidase (spreading factor), L-amino acid oxidase, prothrombinase activator, alpha-fibrinogenase, acetylcholinesterase, and collagenase.
- Sabiston Textbook of Surgery, 7th Ed.
4. Grading of Envenomation Severity
| Grade | Features |
|---|
| None / Dry bite | Fang marks only, no local or systemic effects |
| Mild | Local findings only - pain, ecchymosis, non-progressive swelling |
| Moderate | Clearly progressive swelling, systemic symptoms/signs, laboratory abnormalities |
| Severe | Neurologic dysfunction, respiratory distress, cardiovascular instability/shock |
- Harrison's Principles of Internal Medicine, 22nd Ed.
5. Field Management (Pre-hospital)
What TO Do
- Rapid transport to a medical facility capable of providing antivenom - this is the single most important step
- Remove all jewelry, watches, tight clothing near the bite site (anticipated swelling)
- Wound care - clean with soap and running water, cover with sterile dressing (but do not delay transport for this)
- Splint the limb to limit movement; maintain at approximately heart level in a neutral position
- Keep the victim calm and still - physical activity disperses venom via muscle pumping
- Photograph the snake from a safe distance to assist identification - do not attempt to catch or handle the snake (reflexive bites from dead snakes can still occur)
- Pressure-immobilization technique - recommended specifically for elapid (neurotoxic) bites: wrap the entire bitten limb firmly (snug but not occlusive - one finger should slip under) at 40-70 mmHg for upper limb and 55-70 mmHg for lower limb; immobilize with a splint; carry the patient out
- Do not wash the wound initially - traces of venom on skin can help identify the species and guide antivenom choice
What NOT to Do
-
No incision and suction - exacerbates local tissue damage, increases infection risk, shown to be ineffective
-
No tourniquet for viper bites - viper venom contains procoagulant enzymes; tourniquet concentrates them in a confined space, and release causes sudden venom bolus and risk of embolism
-
No ice/cryotherapy - worsens ischemia
-
No electric shock - ineffective and harmful
-
No traditional/herbal remedies - cause dangerous delays in reaching definitive care
-
Harrison's Principles of Internal Medicine, 22nd Ed.; P.C. Dikshit Textbook of Forensic Medicine and Toxicology
6. Hospital Assessment
History
- Time and location of bite
- Description of snake (color, size, pattern, head shape)
- Symptoms since bite - pain, swelling, paresthesia, weakness, nausea, visual changes
- First-aid measures already applied
- Patient's medical history, medications, allergies (especially equine proteins for older antivenom)
Physical Examination
- Vital signs - BP, HR, RR, temperature, O2 saturation continuously monitored
- Bite wound - fang marks (number, pattern, depth), local swelling, ecchymosis, blistering, necrosis
- Limb circumference - measure every 15 minutes proximal to the bite site until swelling stabilizes, then every 1 hour
- Neurological - ptosis, diplopia, dysarthria, muscle weakness, altered consciousness
- Cardiovascular - hypotension, arrhythmia
- Respiratory - signs of respiratory muscle compromise
Initial Investigations
| Test | Rationale |
|---|
| CBC with differential | Leukocytosis, thrombocytopenia |
| PT/INR, PTT | Coagulopathy/DIC |
| Fibrinogen, fibrin degradation products | Consumptive coagulopathy |
| Metabolic panel (electrolytes, BUN, creatinine) | AKI (common with Russell's viper) |
| Serum CK | Rhabdomyolysis |
| Blood type and cross-match | Anticipate transfusion |
| Urinalysis + urine myoglobin | Hemoglobinuria, myoglobinuria |
| ECG (>50 years or cardiac history) | Arrhythmia |
| ABG (if respiratory compromise) | Ventilatory status |
| Repeat CBC + coagulation every 4 hours if normal; every 6 hours after antivenom if abnormal | |
- Harrison's Principles of Internal Medicine, 22nd Ed.; Tintinalli's Emergency Medicine, Comprehensive Study Guide
7. Antivenom Therapy
Antivenom is the definitive treatment for snake envenomation. Whenever possible, seek expert poison control consultation regarding species-specific indications and dosing.
Indications for Antivenom
- Progressive local swelling crossing joints or involving more than half the bitten limb
- Any systemic envenomation (coagulopathy, neurotoxicity, cardiovascular instability, shock, respiratory distress)
- Moderate or severe envenomation grade
- Confirmed coral snake envenomation (prophylactic, before symptoms develop, because effects are irreversible once established)
Antivenom Types
Crotalinae (pit vipers):
- CroFab (Crotalidae Polyvalent Immune Fab, Ovine) - purified Fab fragments; starting dose 4-6 vials for moderate, 6 vials for severe
- ANAVIP (Crotalidae Immune F(ab')2, Equine) - starting dose 10 vials; longer half-life (~133 hours vs ~15 hours for CroFab), stored at room temperature, less costly per vial
Elapids:
- Coral snake: Anti-venin (M. fulvius), 3-5 vials IV at first confirmed bite
- Cobras, kraits, others: Species-specific polyvalent antivenoms per regional formulary
Administration Protocol
FabAV administration algorithm: Establish initial control with 4-6 vials, then infuse 2-vial maintenance doses at 6, 12, and 18 hours after initial control is achieved. - Tintinalli's Emergency Medicine
- Reconstitute vials and dilute in 250 mL normal saline
- Begin IV infusion at 25-50 mL/h for the first 10 minutes with physician present
- If no reaction, increase to 250 mL/h and complete over 1 hour
- Never give IM or directly into a digit (venom-induced hypovolemia retards absorption; digit injection risks ischemia)
- For FabAV: once initial control is established (cessation of progression of all local effects, systemic effects, coagulopathy), give 2-vial maintenance doses at 6, 12, and 18 hours
- Initial control = cessation of all progression; document initial control carefully - the most common management error is insufficient early dosing
Antivenom Adverse Reactions
| Reaction | Frequency | Management |
|---|
| Acute allergic/anaphylaxis (CroFab) | 6-14% | Stop infusion; epinephrine IM (IV only for severe hypotension); diphenhydramine IV; methylprednisolone 125 mg IV; airway assessment; fluid resuscitation; restart at 5-10 mL/h when controlled |
| Serum sickness (type III hypersensitivity) | 13-16% (CroFab), less with ANAVIP | Urticaria, arthralgia, nephritis 7-21 days post-infusion; treat with corticosteroids tapered over 7-14 days |
Special populations:
-
Children: same number of vials as adults (children receive proportionally more venom per body mass); may reduce total volume
-
Pregnancy: treat when indicated; coagulopathy can be lethal to mother and fetus; reported fetal loss up to 20% in untreated bites, improved with antivenom
-
Sabiston Textbook of Surgery; Tintinalli's Emergency Medicine; Harrison's 22nd Ed.
8. Supportive Management
Resuscitation
- Establish two large-bore IV lines
- If hypotensive: isotonic crystalloid bolus 20-40 mL/kg IV
- Vasopressors for refractory shock if not responsive to fluids and antivenom
- Supplemental oxygen; be prepared for intubation (particularly in elapid bites causing respiratory failure)
Wound Care
- Clean and dress the wound
- Tetanus prophylaxis as indicated
- Antibiotics only if signs of secondary infection (prophylactic antibiotics are not routinely recommended - snake mouths are not the source of serious infection in typical bites)
Coagulopathy / DIC
- Antivenom is the primary treatment - correct coagulopathy first with antivenom before FFP or platelets
- If severe bleeding despite antivenom: FFP, platelets, cryoprecipitate as needed
- Avoid IM injections until coagulopathy is corrected
Neurotoxic Envenomation (Elapids)
- Monitor serial pulmonary function - inspiratory pressure and vital capacity
- Intensive care monitoring for respiratory depression
- Intubation and mechanical ventilation may be required and prolonged
- Neostigmine + atropine may reverse postsynaptic (not presynaptic) neurotoxicity in some elapid envenomations (e.g., cobras); consult poison control
Acute Kidney Injury
- Monitor urine output closely (especially with Russell's viper envenomation)
- Aggressive IV fluid to maintain urine output >0.5 mL/kg/h
- Hemodialysis for oliguria/anuria not responding to fluids
- Systematic review (PMID: 41776424) confirms AKI as a major complication of snake envenomation requiring early recognition
Rhabdomyolysis
- Aggressive IV hydration
- Forced alkaline diuresis (sodium bicarbonate) to prevent renal tubular damage
- Monitor CK, myoglobin, potassium
9. Compartment Syndrome
Local tissue effects of viper bites can raise compartment pressure. Management is distinct:
| Step | Action |
|---|
| 1 | Measure intracompartmental pressure |
| 2 | If <30 mmHg: continue standard management |
| 3 | If signs present + pressure >30 mmHg: elevate limb |
| 4 | Administer mannitol 1-2 g/kg IV over 30 minutes |
| 5 | Simultaneously administer additional antivenom over 60 minutes |
| 6 | If elevated pressure persists 60 minutes later: consider fasciotomy |
The most effective treatment for compartment syndrome from snakebite is neutralization of venom with antivenom, not immediate surgery. Fasciotomy is a last resort.
- Tintinalli's Emergency Medicine
Extensive ecchymosis from severe rattlesnake envenomation (ankle bite, 5 days post):
- Harrison's Principles of Internal Medicine, 22nd Ed.
10. Special Considerations by Snake Type
Viper Bites (Crotalinae and Viperinae)
- Dominant local effects (swelling, hemorrhage, necrosis) + systemic hemotoxicity
- Pressure-immobilization not recommended (may worsen local tissue damage from necrotizing venom)
- Antivenom is the mainstay; dose driven by severity
- Watch for DIC, AKI, compartment syndrome, hypovolemic shock
Elapid Bites (Cobra, Krait, Coral Snake)
- Minimal local effects, predominantly neurotoxic
- Pressure-immobilization technique is appropriate here
- Admit all confirmed bites for observation - symptoms may be delayed hours
- Give antivenom preemptively for confirmed coral snake bite; neurological effects, once established, cannot be reversed
- Prolonged ICU ventilatory support may be needed
- Spitting cobras: ocular venom exposure - irrigate eyes immediately with copious water/saline; ophthalmic review
Sea Snakes (Hydrophiinae - Elapidae)
- Up to 75% dry bites
- True envenomation causes generalized myalgia, trismus, bulbar paralysis, myoglobinuria
- Treat with sea snake antivenom (polyvalent)
11. Criteria for Discharge and Follow-up
Patients are ready for discharge when:
- Swelling begins to resolve
- Coagulopathy has been reversed and remains stable
- Patient is ambulatory
Outpatient instructions:
- Physical therapy for the bitten extremity (especially hand) once swelling and coagulopathy resolve
- Return to ED if symptoms recur, bruising reappears, or signs of recurrent coagulopathy develop
- Educate on symptoms of serum sickness (urticaria, joint pains, fever 7-21 days post-bite) and advise to return
12. What Not to Do - Summary
| Harmful Intervention | Why It Is Harmful |
|---|
| Incision and suction | Worsens local damage, increases infection risk, ineffective |
| Tourniquet (viper bites) | Concentrates procoagulant venom; embolic risk on release |
| Ice / cryotherapy | Causes ischemia, worsens necrosis |
| Electric shock therapy | No evidence of benefit; harmful |
| Traditional/herbal healers | Delays definitive care, major contributor to mortality |
| IM antivenom or into digits | Poor absorption, ischemia risk |
| Catching the snake | Risk of second bite; photograph instead |
13. Summary Algorithm
SNAKEBITE
|
v
PREHOSPITAL: Remove jewelry → Clean wound → Splint limb at heart level
Elapid bite? → Pressure-immobilization bandage → Carry (do NOT walk)
Viper bite? → Do NOT use pressure bandage → Rapid transport
|
v
EMERGENCY: ABC assessment → 2 large-bore IVs → O2 → Monitoring
|
v
IDENTIFY: Species if possible, grade severity (none/mild/moderate/severe)
|
v
LABS: CBC, coag, fibrinogen, metabolic, CK, U/A, type & cross
|
v
ANTIVENOM (if moderate/severe/any systemic sign):
Pit viper → CroFab 4-6 vials / ANAVIP 10 vials IV over 1h
Coral snake → Anti-venin (M. fulvius) 3-5 vials IV
Cobra/krait → Regional polyvalent antivenom
|
v
MONITOR: Repeat limb measurements, labs q4-6h
|
v
TREAT COMPLICATIONS:
Shock → Crystalloid bolus ± vasopressors
Coagulopathy → Antivenom first; FFP/platelets if severe bleeding
AKI → IV fluids, dialysis if needed
Compartment → Mannitol + antivenom; fasciotomy last resort
Respiratory failure → Intubation ± ventilator
Neurotoxicity → ICU monitoring; neostigmine for postsynaptic elapid
|
v
DISCHARGE: Stable labs → Ambulatory → Serum sickness education → F/U
Sources
- Harrison's Principles of Internal Medicine, 22nd Edition (2025) - Chapter 471
- Tintinalli's Emergency Medicine: A Comprehensive Study Guide - Chapter 212
- Sabiston Textbook of Surgery, Biological Basis of Modern Surgical Practice - Chapter 44
- Mulholland and Greenfield's Surgery, Scientific Principles and Practice, 7th Ed.
- P.C. Dikshit Textbook of Forensic Medicine and Toxicology
Recent evidence note: A 2026 systematic review and meta-analysis (PMID:
41776424) confirms AKI as a major complication of snake envenomation across multiple species; early renal monitoring and intervention is supported. A 2025 systematic review (PMID:
40691949) on snakebite outcomes in high-incidence Asian countries highlights the continued burden of delayed presentation and inadequate antivenom access as primary drivers of poor outcomes.